IMPORTANT INFORMATION
Due to legal restrictions, this part of the Sprint Biosciences website is not accessible to certain persons. We therefore ask you to read the following information and provide the following confirmation each time you wish to access these web pages. Please note that the terms and conditions below may be changed or updated and it is therefore important that you read them each time you visit this page.
The information contained in this portion of the Sprint Biosciences website is not intended for, and may not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons residing or located in the United States (including its territories and possessions, any state of the United States, and the District of Columbia) ("USA"), Australia, Canada, New Zealand, Hong Kong, Japan, South Korea, Singapore, Switzerland, South Africa or any other jurisdiction where such action is wholly or partially subject to legal restrictions, or would require additional prospectuses, registration or other measures than those required by Swedish law. The information on the websites does not constitute an offer of unit rights, paid subscription units or units issued by Sprint Bioscience ("Securities") to any person in those jurisdictions. Nor may the information on the websites be forwarded or reproduced in a manner that contravenes such restrictions or would impose such requirements.
No Securities have been or will be registered under the United States Securities Act of 1933, as amended, or the securities laws of any state or other jurisdiction of the United States and may not be offered, subscribed for, exercised, pledged, sold, resold, assigned, delivered or otherwise transferred, directly or indirectly, in or into the United States, except pursuant to an exemption accepted by Sprint Bioscience.
Sprint Bioscience reserves the right, subject to any applicable exemption, to accept subscriptions from a person who is located or registered in a jurisdiction where participation would otherwise require additional prospectuses, registration or other measures than those required by Swedish law.
Within the European Economic Area (”SEA"), no offer to the public of Securities is made in any country other than Sweden. In other member states of the European Union ("EU”), such offer may only be made in accordance with the exemptions set out in the Prospectus Regulation (EU) 2017/1129 (”Prospectus Regulation"In other countries in the EEA that have implemented the Prospectus Regulation into national law, such offer can only be made in accordance with the exemptions in the Prospectus Regulation and in accordance with any relevant implementing measures. In other countries in the EEA that have not implemented the Prospectus Regulation into national law, such offer can only be made in accordance with the applicable exemption in the national law.
In order to access the information on this part of the Sprint Biosciences website, all persons must first ensure that they are not subject to any legal restrictions limiting their ability to access the information on this part of the Sprint Biosciences website.
We therefore ask you to confirm that you are resident or located outside the United States, Australia, Canada, New Zealand, Hong Kong, Japan, South Korea, Singapore, Switzerland, South Africa or any other jurisdiction where such action is wholly or partly subject to legal restrictions, or would require additional prospectuses, registration or other measures than those required by Swedish law and are entitled to access the information on these web pages without restriction by law or other rules and without the need for further action by Sprint Bioscience. We also ask you to confirm that you have read the information, conditions and restrictions above and that you agree to comply with them.
IMPORTANT INFORMATION
The information contained in this part of the website is not intended for persons residing or located in any jurisdiction (including the United States, Australia, Canada, New Zealand, Hong Kong, Japan, South Korea, Singapore, Switzerland, South Africa) where distribution of the information contained in this part of the website would require additional measures to be taken or would be contrary to the laws or regulations of that jurisdiction. You have either not complied with this condition or have not provided the necessary confirmations. You cannot therefore access this part of the website.
